Compare ImmunityBio Inc. Common Stock (IBRX) vs Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF (PDBC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF — how do they compare? ImmunityBio Inc. Common Stock trades at $10.53 (market cap $10.51B), while Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF trades at $19.7 (market cap $7.77B). The key difference: ImmunityBio Inc. Common Stock is the larger of the two by market cap, and ImmunityBio Inc. Common Stock is more actively traded (10,445,785 versus 6,100,303). Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 1 Days and Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF for 56 Days on average.
| IBRX | PDBC | |
|---|---|---|
Market Cap | $10.51B | $7.77B |
Volume | 10,445,785 | 6,100,303 |
Sector | Health | — |
52-Week High | $11.55 | $20.10 |
52-Week Low | $1.98 | $13.16 |
Typical Hold Time | 1 Days | 56 Days |
Enterprise Value | $10.97B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
PDBC (Invesco Optimum Yield Diversified Commodity Strategy ETF) trades at $19.68, up 1.39% with strong bullish momentum. The ETF has delivered exceptional performance, rising 45.66% year-to-date driven by energy and agricultural gains amid geopolitical turmoil. Technical indicators show bullish moving averages but neutral oscillators, with RSI at 72.89 suggesting potential overbought conditions. Recent institutional activity shows significant position increases despite a 215% surge in short interest.
The outlook remains positive given strong commodity trends and defensive positioning appeal, though elevated short interest and geopolitical risks warrant caution. Commodity exposure provides inflation hedge benefits, but price volatility and concentrated sector risks require careful monitoring for investors seeking diversified commodity exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF
The fund is an actively managed exchange-traded fund ("ETF") that seeks to achieve its investment objective by investing in a combination of financial instruments that are economically linked to the world's most heavily traded commodities. Commodities are assets that have tangible properties, such as oil, agricultural produce or raw metals.
Read more on PDBC →
